Title : Hedgehog signaling promotes sorafenib resistance in hepatocellular carcinoma patient-derived organoids.

Pub. Date : 2020 Jan 28

PMID : 31992334






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Furthermore, CD44-positive HCC PDOs were obviously resistant to sorafenib, and sorafenib increased CD44 levels. Sorafenib CD44 molecule (Indian blood group) Homo sapiens
2 Furthermore, CD44-positive HCC PDOs were obviously resistant to sorafenib, and sorafenib increased CD44 levels. Sorafenib CD44 molecule (Indian blood group) Homo sapiens
3 Furthermore, CD44-positive HCC PDOs were obviously resistant to sorafenib, and sorafenib increased CD44 levels. Sorafenib CD44 molecule (Indian blood group) Homo sapiens
4 In addition, there was a highly synergistic effect in vitro and in vivo on the suppression of cell viability and malignant properties when sorafenib and GANT61 were added to CD44-positive HCC PDOs and cell lines, respectively. Sorafenib CD44 molecule (Indian blood group) Homo sapiens
5 Furthermore, the upregulation of CD44 and Hedgehog signaling induced by sorafenib was reversed by GANT61. Sorafenib CD44 molecule (Indian blood group) Homo sapiens
6 CONCLUSIONS: GANT61 significantly suppressed Hedgehog signaling to reverse sorafenib resistance in CD44-positive HCC. Sorafenib CD44 molecule (Indian blood group) Homo sapiens
7 The combination of sorafenib and Hedgehog signaling inhibitors might be effective in HCC patients with high CD44 levels as a personalized-medicine approach. Sorafenib CD44 molecule (Indian blood group) Homo sapiens